Thanks to everyone for all of their great questions and converstions on this site.
Check my bio for background. 2 months into ADT therapy after diagnosis in January. I am starting docetaxyl chemo via an NIH trial in May. M9241 - ncbi.nlm.nih.gov/pmc/articl.... We are hopeful for both good chemo results as well as a positive response for the immunotherapy. This trial stage is mostly to test feasability or delivering immunotherapy along with chemotherapy.
Is anyone familiar with, or perhaps a patient, of this study that can share any thoughts?